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We tested the hypothesis that personality plays a role in cancer outcome in a population-based prospective cohort study in Japan. In
July 1990, 41442 residents of Japan completed a short form of the Eysenck Personality Questionnaire-Revised and a questionnaire on
various health habits, and between January 1993 and December 1997, 890 incident cases of cancer were identified among them.
These 890 cases were followed up until March 2001, and a total of 356 deaths from all causes was identified among them. Cox
proportional-hazards regression was used to estimate the hazard ratio (HR) of death according to four score levels on each of four
personality subscales (extraversion, neuroticism, psychoticism, and lie), with adjustment for potential confounding factors.
Multivariable HRs of deaths from all causes for individuals in the highest score level on each personality subscale compared with those
at the lowest level were 1.0 for extraversion (95% CI¼0.8–1.4; Trend P¼0.73), 1.1 for neuroticism (0.8–1.6; Trend P¼0.24), 1.2
for psychoticism (0.9–1.6; Trend P¼0.29), and 1.0 for lie (0.7–1.5; Trend P¼0.90). The data obtained in this population-based
prospective cohort study in Japan do not support the hypothesis that personality is associated with cancer survival.
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Psychological factors may alter immune and endocrine function
with possible effects on cancer incidence and outcome (Kiecolt-
Glaser and Glaser, 1999; Spiegel and Kato, 1996), and the
possibility that personality plays a role in cancer aetiology and
outcome has often been raised (Garssen and Goodkin, 1999). The
results of our earlier study, however, do not support the hypothesis
that personality traits measured by the Eysenck questionnaire
(extroversion, neuroticism, psychoticism, and lie) are risk factors
for cancer (Nakaya et al, 2003).
The role of personality in the causation of cancer survival has
been controversial. Of the four studies of cancer survival using the
Eysenck questionnaire, one found statistically significant associa-
tions between higher scores for lie and increased risk of death in
Hodgkin’s disease or non-Hodgkin’s lymphoma patients (Ratcliffe
et al, 1995) and lower scores for extraversion (Hislop et al, 1987)
(Ratcliffe et al, 1995) and breast cancer patients (Hislop et al,
1987). Two others found no association between extraversion or
neuroticism and death in postoperative breast cancer patients
(Greer et al, 1979; Dean and Surtees, 1989). However, these studies
had several limitations, including failure to control for cigarette
smoking or alcohol consumption, and failing to assess personality
before the cancer diagnosis.
We conducted a population-based prospective cohort study in
Japan to further investigate associations between the personality
traits and cancer survival. To our knowledge, this is the first such
study to assess personality before the diagnosis of cancer.
MATERIALS AND METHODS
Study cohort
We have reported the design of this prospective cohort study
in detail elsewhere (Fukao et al, 1995; Nakaya et al, 2003; Suzuki
et al, 2004). Briefly, we delivered two self-administered question-
naires to all 51921 residents aged 40–64 years in 14 municipalities
of Miyagi Prefecture in rural northern Japan from June through
August 1990. The first questionnaire asked about various
health habits, and the second was the Japanese version of the
Eysenck Personality Questionnaire-Revised (EPQ-R) Short Form
(Hosokawa and Ohyama, 1993). The questionnaires were deli-
vered to, and collected at, the subjects’ residences by members
of health promotion committees appointed by the municipal
governments. The response rate for the first questionnaire was
91.7% (n¼47605), and that for the second questionnaire among
the respondents to the first was 79.8% (n¼41442). The study
protocol was approved by the institutional review board of Tohoku
University Graduate School of Medicine. We considered the return
of self-administered questionnaires signed by the subjects to imply
their consent to participate in the study.
Exposure data
The first questionnaire asked about demographic variables,
personal and family histories of cancer and other diseases, and
Received 1 February 2005; revised 17 March 2005; accepted 4 April
2005; published online 17 May 2005
*Correspondence: Dr Y Uchitomi; E-mail: yuchitom@east.ncc.go.jp
British Journal of Cancer (2005) 92, 2089–2094
& 2005 Cancer Research UK All rights reserved 0007– 0920/05 $30.00
www.bjcancer.com
E
p
i
d
e
m
i
o
l
o
g
yhealth habits, including smoking, alcohol use, diet, use of health
services, and self-reported height and weight. The second
questionnaire was a Japanese translation of the original English
version of the EPQ-R Short Form, one of the series of personality
inventories developed by Eysenck and Eysenck (1975). It contains
48 questions with dichotomised responses (yes or no); there are 12
questions for each of the four subscales (extraversion, neuroticism,
psychoticism, and lie). Scores on each subscale ranged from 0 to
12, with higher scores indicated a greater tendency to possess the
personality trait represented by each subscale. Extraversion
represents sociability, liveliness, and surgency; neuroticism
represents emotional instability and anxiousness; Psychoticism
represents tough-mindedness, aggressiveness, coldness, and ego-
centricity; and lie represents unsophisticated dissimulation and
social naivety or conformity (Eysenck and Eysenck, 1991).
In a previous study, we developed the Japanese version of the
questionnaire and evaluated its reproducibility and validity among
329 college students and 253 adults (Hosokawa and Ohyama,
1993). Cronbach’s alpha coefficient, a measure of internal
consistency, was greater than 0.70 for all subscales except
psychoticism (0.42 for college students and 0.48 for adults). The
test–retest reliability coefficients of the four subscales over a 6-
month period ranged from 0.70 to 0.85, indicating substantial
stability. Confirmatory factor analysis supported the original
theoretical structure of the four subscales proposed by Eysenck
and Eysenck (1975). Scores on the four subscales were highly
correlated with scores on similar subscales in the Japanese
versions of the Sixteen Personality Factor Questionnaire (Izawa
et al, 1982) and the Maudsley Personality Inventory (MPI
Kenkyukai, 1969), indicating that the questionnaire had a high
degree of concurrent validity.
Follow-up
Population registries in the 14 municipalities were used to
ascertain the vital and residential status of the subjects from 1
June 1990 through 31 December 1997, and 1609 incident cases of
cancer were identified by computerised record linkage with the
Miyagi Prefectural Cancer Registry covering the study area
(Takano and Okuno, 1997). We excluded subjects with cancer
diagnosed in the first 3 years from the baseline (n¼451) because
clinical stage of cancer was not recorded in the Miyagi Prefectural
Cancer Registry for cases registered between June 1990 and
December 1992.
Among the 1158 incident cases of cancer, we excluded subjects
who responded ‘yes’ or ‘no’ to all 48 items on the EPQ-R, or failed
to respond to any of them (n¼168). We also excluded 100 subjects
who indicated that they had completed the two questionnaires with
the assistance of family members, because we suspected that
might have affected the response patterns. Ultimately, data for
890 subjects (505 men and 385 women), with 356 deaths from all
causes (241 men and 115 women), were used in the analysis.
Statistical analysis
We counted person-years of follow-up for each subject from the
date of diagnosis of cancer (from 1 January 1993 through 31
December 1997) until the date of emigration from the study
districts, or the end of the study period (31 March 2001),
whichever occurred first. A total of 3331 person-years accrued,
and mean (s.d.) was 3.7 (2.5) years per person. Owing to logistical
limitations, we discontinued follow-up of subjects who emigrated
from the study municipalities, and as a result 22 subjects (2.5% of
the analytic cohort) were lost to follow-up during the study period.
The numbers of subjects differed for each personality subscale,
because subjects were excluded from the analyses of any subscale
if answers to any of the questions on that subscale were missing.
The number of subjects whose data were used for the analysis of
extraversion, neuroticism, psychoticism, and lie was 825, 822, 819,
and 819, respectively. The scores on each personality subscale
(scored on a scale of 0–12) were divided into four score levels
approximately equal in size based on the scores of the subjects as a
whole. As a result, the cutoff scores vary with the subscale. Hazard
ratios (HRs) were computed as the death rate among subjects in
each score level of a personality subscale divided by the death rate
among subjects in the lowest score level. Hazard ratios were also
estimated by analysing deaths from all causes and deaths from
cancer.
We used the SAS PHREG procedure on SAS version 8.2
statistical software package (Cary, NC, USA) to evaluate Cox
proportional-hazard regression to adjust for sex, age in years at
cancer diagnosis, and other potentially confounding variables
(Rothman and Greenland, 1998). P-values for testing statistical
significance of linear trends were calculated by treating personality
subscales as continuous variables. All P-values were two-tailed.
In addition to sex and age in years at cancer diagnosis, we
considered the following variables to be potential confounders a
priori: clinical stage (in situ or localised, lymph node metastasis,
regional invasion, distant metastasis); surgery (with excision of the
primary lesion or without excision of the primary lesion); method
of diagnosis (mass screening and health checkup or other); initial
cancer site (stomach, colorectum, lung, breast, or other sites); past
history (stroke, myocardial infarction, hypertension, diabetes
mellitus); education (up to 15 years of age, from 16 to 18 years,
19 years or older); marital status (whether or not living with
spouse); cigarette smoking (never smoker, past smoker, current
smoker); alcohol consumption (never drinker, past drinker,
current drinker). This study used the clinical staging system
developed by the Research Group for Population-Based Cancer
Registration in Japan. Lesions at each cancer site were classified
into four stages (in situ or localised, lymph node metastasis,
regional invasion, distant metastasis) based on the SEER Program
(Surveillance, Epidemiology, and End Results Program) and the
UICC-TNM classification (Research Group for Population-Based
Cancer Registration in Japan, 1999). We further assessed associa-
tions between clinical stage and risk of death from all causes.
Stratified analyses were performed according to sex, age group
in years at cancer diagnosis (10-year age class), clinical stage,
surgery, occasion of diagnosis, past history (stroke, myocardial
infarction, hypertension, or diabetes mellitus), cigarette smoking,
alcohol consumption, education, marital status, and initial major
cancer sites. The four most common cancer sites among the
subjects, namely, stomach, colorectum, lung, and breast, were used
as the major cancer sites. Combinations of cancer sites consisting
of digestive organs or respiratory organs were also used (World
Health Organization, 1992; Schapiro et al, 2001).
RESULTS
We first compared the characteristics of the subjects in the highest
and lowest levels (i.e., approximate quartiles) of score on each
personality subscale (Table 1). Subjects in the highest level for
extraversion were more likely to live with a spouse and current
smoker and less likely to have a past history of hypertension; those
in the highest level for neuroticism were more likely to be female,
have in situ or localised as their clinical stage, and a past history of
hypertension, and less likely to be living with a spouse and be a
current smoker. Subjects in the highest level for psychoticism were
more likely to be a man, current smoker, and current drinker.
Subjects in the highest level for lie were older, more likely to be a
woman, to have been diagnosed by mass screening or a health
checkup, and less likely to be living with a spouse, be a current
smoker, or current drinker.
The clinical stages of the cancers were strongly associated with
risk of death from all causes: The multivariate HRs for in situ or
Personality and cancer survival
N Nakaya et al
2090
British Journal of Cancer (2005) 92(11), 2089–2094 & 2005 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
ylocalised (95% CI) were 3.2 (1.9–5.3), 5.4 (3.4–8.4), and 7.3
(4.8–11.3) in subjects with lymph node metastasis, regional
invasion, and distant metastasis, respectively.
The multivariable Cox proportional-hazards regression analyses
showed no significant associations between any of the four
personality subscales and the HR of death from all causes (Table 2),
and these findings remained basically unchanged when we tested
for associations between four personality subscales and the risk of
death from cancer. We divided each personality subscale into
tertiles or quintiles as closely as possible so our observations were
quite similar and replicated (data not shown).
Stratified analyses according to sex, age group in years at cancer
diagnosis, clinical stage, surgery, occasion of diagnosis, past
history, education, marital status, cigarette smoking, and alcohol
consumption showed that the associations between personality
subscales and risk of death from all causes were not markedly
affected by any of these variables (data not shown).
The multivariable Cox proportional-hazards regression analyses
also showed no significant associations between personality
subscales and risk of death from all causes stratified by the four
major cancer sites (stomach, colorectum, lung, and breast)
(Table 3). For stomach cancer, extraversion and neuroticism
showed slightly (but not significantly) higher risk of death from all
causes. For lung cancer, neuroticism showed a slightly lower
(nonsignificant) risk of death from all causes. No significant
associations were also found in the combinations of cancer sites
(digestive and respiratory organs).
DISCUSSION
This population-based prospective cohort study in rural Japan
revealed no significant association between any of the four
personality traits measured by the Eysenck questionnaire (extra-
version, neuroticism, psychoticism, and lie) in cancer patients and
risk of death from all causes.
Four earlier studies investigated association between scores on
the subscale of the Eysenck questionnaire and cancer survival. One
followed up 63 cases of Hodgkin’s disease or non-Hodgkin’s
lymphoma for 5 years, with 27 deaths from all causes and found a
significant positive, linear association between lie and the risk of
death from all causes (trend P¼0.001) (Ratcliffe et al, 1995).
Table 1 Characteristics of the subjects according to scores in the highest and lowest of four score levels of each of personality subscales
Personality subscale score levels
a
Extraversion (n¼825) Neuroticism (n¼822) Psychoticism (n¼819) Lie (n¼819)
Characteristics p3 X9 p3 X9 p3 X6 p5 X10
No. 248 172 243 174 277 205 181 202
Men (%) 59.7 59.3 60.5 55.2 39.4 79.2 69.6 47.0
Cancer registration at cancer diagnosis
Age in years at cancer diagnosis, means7s.d. 60.676.9 60.976.5 61.377.0 60.077.5 60.577.2 60.276.8 58.677.6 62.575.7
Initial cancer site (%)
Stomach 22.2 23.3 22.2 23.0 19.9 25.9 22.1 20.3
Colorectum 18.6 16.9 18.1 16.1 15.5 16.1 17.1 18.3
Lung 13.3 10.5 14.4 10.3 9.8 12.2 9.9 14.9
Breast 10.1 10.5 7.8 12.1 12.6 6.3 9.4 7.9
Other sites 35.9 39.0 37.5 38.5 42.2 39.5 41.4 38.6
Clinical stage (%)
In situ or localised 37.7 34.9 35.4 44.8 40.4 34.2 40.9 35.1
Lymph node metastasis 8.5 11.6 12.4 8.0 10.1 12.7 7.7 10.9
Regional invasion 8.9 7.6 9.5 8.6 9.4 6.8 10.5 7.9
Distant metastasis 12.6 12.2 11.9 10.3 10.8 12.7 11.1 11.9
Unknown 32.4 33.7 30.9 28.2 29.2 33.7 29.8 34.2
Surgery (%)
Surgery with excision of the primary lesion 66.9 70.4 68.3 69.0 71.5 64.4 66.3 68.8
Surgery without excision of the primary lesion 17.3 16.3 16.0 17.2 15.9 19.0 18.8 15.8
Unknown 15.7 13.4 15.6 13.8 12.6 16.6 14.9 15.3
Occasion of diagnosis (%)
Mass screening or health checkup 28.2 27.3 30.5 28.2 29.6 23.9 24.9 31.7
Other 48.8 50.0 48.6 46.0 47.7 52.7 53.0 45.0
Unknown 23.0 22.7 21.0 25.9 22.7 23.4 22.1 23.3
Self-report questionnaire at 1990
Past history (%)
Stroke 0.4 0.0 0.4 0.6 0.0 1.5 1.1 0.0
Myocardial infarction 0.0 1.7 2.1 1.2 1.1 2.4 2.8 2.0
Hypertension 30.2 20.9 18.9 28.2 28.2 26.3 26.0 22.8
Diabetes mellitus 6.1 5.2 4.1 6.9 5.8 7.3 7.2 5.5
Education, in school until age 19 years or older (%) 13.7 15.1 12.4 12.1 15.9 7.8 11.1 12.4
Marital status, living with spouse (%) 79.8 85.5 88.1 79.3 83.8 83.9 89.0 82.2
Current smoker (%) 38.3 44.2 47.3 39.1 27.4 59.5 52.5 31.7
Current drinker (%) 51.2 55.8 56.4 55.2 43.0 63.4 65.8 38.1
aThe scores on each personality subscale (scored on a scale of 0–12) were divided into four score levels approximately equal in size based on the scores of the subjects as a
whole, and as a result the cutoff scores vary with the subscale.
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6–8 years, identifying 22 deaths from all causes but found no
significant associations with extraversion, neuroticism, or lie
(Dean and Surtees, 1989). In a follow up of 133 cases of breast
cancer for 4 years, with 26 deaths from all causes, a significant
negative association was observed between extraversion and the
risk of death (multivariate HR¼0.33, Po0.05) (Hislop et al, 1987).
Neuroticism was not associated with risk of death (multivariate
HR¼0.85, P40.05). Lastly, in a follow up of 69 cases of breast
cancer for 5 years with 18 deaths from all causes, there were no
significant associations with extraversion or neuroticism (Greer
et al, 1979).
Other studies have mainly focused on the possible association
between psychological factors, including component factors of
type C personality (Temoshok et al, 1985), such as emotional
suppression, helplessness/hopelessness, and cancer survival. In a
recent large prospective cohort study, 578 cases of early-stage
breast cancer were followed up for at least 5 years with 133 deaths
from all causes; emotional suppression and helplessness/hope-
lessness did not increase the risk of death (Watson et al, 1999).
There is also little consistent evidence from other studies that these
factors are important in cancer survival (Petticrew et al, 2002). Our
findings also suggested that Eysenck personality dimensions do
not substantially influence cancer survival.
Our study had several methodologic advantages over previous
studies of personality and cancer survival. First, we controlled
extensively for potential confounding variables, including cigarette
smoking and alcohol consumption. Various studies have reported
that smoking or alcohol consumption are associated with
extraversion or other personality characteristics (McManus and
Weeks, 1982; Arai et al, 1997; Vollrath and Torgersen, 2002;
Nakaya et al, 2003) as well as cancer outcome (Deleyiannis et al,
1996; Oh et al, 2000; Tammemagi et al, 2004). We observed little
differences in the point estimates of the HRs according to whether
multivariate adjustments were made for smoking and other
variables (Table 2). Second, we assessed the responses to the
personality questionnaire before the diagnosis of cancer, and to
our knowledge this is the first study on associations between
personality before cancer diagnosis and the risk of death from all
causes. All earlier studies assessed the responses to personality
questionnaire after the cancer diagnosis, and the personality scores
may have been influenced by the cancer diagnosis or by treatment.
Our assessment of personality was free from such distortions.
One strength of our study is the exclusion of subjects with
cancer in the first 3 years of follow-up, because clinical stage was
not recorded in the Miyagi Prefectural Cancer Registry for cases
registered between June 1990 and December 1992. This would have
improved the validity of our findings, since such cancers
Table 2 Results of Cox proportional-hazards regression analysis of EPQ-R subscales scores and cancer survival
a
Personality subscale score levels
b
1 (reference) 2 3 4 Trend P-value
c
Extraversion (n¼825)
Score p34 – 5 6 – 8 X9
Person-years of follow-up 943 704 844 659
No. of death (all-cause/cancer) 97/88 63/60 93/85 69/63
Age-, sex-adjsuted HR1 1.0 0.9 (0.7–1.3) 1.1 (0.8–1.5) 1.0 (0.7–1.4) 0.62
Multivariable HR1 1.0 0.8 (0.6–1.1) 1.1 (0.8–1.4) 1.1 (0.8–1.4) 0.73
Multivariable HR2 1.0 0.8 (0.6–1.1) 1.1 (0.8–1.5) 1.0 (0.7–1.5) 0.65
Neuroticism (n¼822)
Score p34 – 5 6 – 8 X9
Person-years of follow-up 899 700 835 674
No. of death (all-cause/cancer) 96/86 58/54 104/99 68/62
Age-, sex-adjsuted HR1 1.0 0.8 (0.6–1.2) 1.1 (0.9–1.5) 1.0 (0.8–1.4) 0.32
Multivariable HR1 1.0 0.9 (0.6–1.3) 1.1 (0.8–1.4) 1.1 (0.8–1.6) 0.24
Multivariable HR2 1.0 0.9 (0.7–1.3) 1.1 (0.8–1.5) 1.2 (0.8–1.7) 0.17
Psychoticism (n¼819)
Score p345 X6
Person-years of follow-up 1100 787 482 700
No. of death (all-cause/cancer) 97/89 81/78 50/47 97/90
Age-, sex-adjsuted HR1 1.0 1.1 (0.8–1.5) 1.0 (0.7–1.5) 1.2 (0.8–1.7) 0.20
Multivariable HR1 1.0 1.1 (0.8–1.5) 0.9 (0.7–1.3) 1.2 (0.9–1.6) 0.29
Multivariable HR2 1.0 1.2 (0.8–1.6) 1.0 (0.7–1.4) 1.2 (0.9–1.7) 0.31
Lie (n¼819)
Score p56 – 78 – 9 X10
Person-years of follow-up 660 745 923 754
No. of death (all-cause/cancer) 72/66 68/64 105/99 79/71
Age-, sex-adjsuted HR1 1.0 0.9 (0.6–1.3) 1.0 (0.8–1.4) 0.9 (0.7–1.3) 0.61
Multivariable HR1 1.0 0.9 (0.6–1.2) 1.0 (0.7–1.4) 1.0 (0.7–1.5) 0.90
Multivariable HR2 1.0 0.9 (0.6–1.3) 1.0 (0.7–1.4) 1.0 (0.7–1.5) 0.88
aThe multivariate hazard ratio (HR) has been adjusted for sex; age in years at cancer diagnosis (40–49, 50–59, or 60 years or older); clinical stage (in situ or localised, lymph node
metastasis, regional invasion, distant metastasis); surgery (with excision of the primary lesion or without excision of the primary lesion); occasion of diagnosis (mass screening and
health checkup, others); initial cancer site (stomach, colorectum, lung, breast, other sites); past history (stroke, myocardial infarction, hypertension, diabetes mellitus); education
(up to 15 years of age, from 16 to 18 years, 19 years or older); marital status (whether living with a spouse); cigarette smoking (never smoker, past smoker, or current smoker);
alcohol consumption (never drinker, past drinker, or current drinker). HR1¼hazard ratio of death from all causes as an end point; HR2¼hazard ratio of death from cancer as an
end point. All HRs are reported with the 95% confidence interval (CI) in parentheses. EPQ-R¼Eysenck Personality Questionnaire-Revised (EPQ-R) Short Form.
bThe scores on
each personality subscale (scored on a scale of 0–12) were divided into four score levels approximately equal in size based on the scores of the subjects as a whole. As a result,
the cutoff scores vary with the subscale.
cP-values for linear trend were calculated by treating personality subscales as continuous variables.
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have distorted responses because of to subclinical symptoms
caused by as-yet diagnosed cancers.
Limitations of our study include the small number of subjects
with cancer at specific sites. Although we found no significant
association between any of the four personality trait and risk of
death among the subjects with the commonest cancers, the
analyses may not have had sufficient statistical power to detect
associations between small increases or decreases in the risk of
death from all causes at individual sites and personality traits.
Third, we had no information on health behaviours after the
cancer diagnosis or on compliance with treatment.
In conclusion, the data obtained in this population-based
prospective cohort study in rural Japan do not support the
hypothesis that personality is associated with cancer survival. We
suggest that cancer patients should not feel pressured into
adopting a particular personality to improve their survival.
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Multivariable HR 0.5 (0.2–1.3) 0.17 1.0 (0.3–3.0) 0.36 0.9 (0.2–3.0) 0.78 0.7 (0.3–1.3) 0.32
Lung 91/59 95/63 87/59 89/58
Multivariable HR 0.9 (0.3–2.4) 0.65 0.4 (0.1–1.1) 0.94 1.1 (0.4–3.1) 0.77 1.2 (0.4–3.1) 0.77
Breast 77/11 73/10 80/12 74/11
Multivariable HR 0.5 (0.0–31.2) 0.20 Not applicable Not applicable Not applicable
Combinations of cancer sites (No. of subjects/deaths from all-cause)
c
Digestive organs
d 370/118 364/120 366/121 361/121
Multivariable HR 0.9 (0.5–1.6) 0.90 0.9 (0.5–1.4) 0.88 0.8 (0.5–1.4) 0.32 1.0 (0.5–1.8) 0.59
Respiratory organs
e 108/61 113/65 105/61 107/60
Multivariable HR 0.9 (0.3–3.0) 0.96 0.5 (0.2–1.6) 0.78 1.2 (0.5–2.2) 0.07 0.8 (0.3–2.4) 0.80
aThe multivariate hazard ratio (HR) has been adjusted for sex; age in years at cancer diagnosis (40–49, 50–59, or 60 years or older); clinical stage (in situ or localised, lymph node
metastasis, regional invasion, distant metastasis); surgery (with excision of the primary lesion or without excision of the primary lesion); occasion of diagnosis (mass screening and
health checkup, others); past history (stroke, myocardial infarction, hypertension, diabetes mellitus); education (up to 15 years of age, from 16 to 18 years, 19 years or older);
marital status (whether living with a spouse); cigarette smoking (never smoker, past smoker, or current smoker); alcohol consumption (never drinker, past drinker, or current
drinker). Hazard ratio denotes hazard ratio of death from all causes as an end point. All HRs are reported with the 95% confidence interval (CI) in parentheses.
bP-values for
linear trend were calculated by treating personality subscales as continuous variables.
cThe total numbers of subjects or deaths from all causes were used in the analyses.
dDigestive organs: oesophagus, stomach, small intestine, colon, rectum, and anus.
eRespiratory organs: nasal cavity, middle ear, accessory sinuses, larynx, trachea, bronchus, and
lung.
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